References
- Miller RD : Anesthesia. 5th edition. Gronert GA, Antognini JFm, Pessah IN. pp1033
- Denborough MA, Lovell RRH : Anesthetic deaths in a family. [Letter] Lancet 2 : 45, 1960
- Ellis FR, Halsall PJ, Christian As : Clinical presentation of suspected malignant hyperthemia during anesthesia in 402 probands. anesthesia 45 : 838, 1990 https://doi.org/10.1111/j.1365-2044.1990.tb14566.x
- Allen GC, LArach MG, Kunselman AR : The sensitivity and specificity of the caffeine-halothane contracture test : A report From the North American malignant hyperthermia registry. anesthesiology 88 : 579, 1998 https://doi.org/10.1097/00000542-199803000-00006
- Rosenberg H. Malignant Hyperthermia syndrome. Anesth Anal 56 : 456, 1977
- Otsuka, Komura Y, Mayumi T, Yamamura T, Kemmotsu, Mukaida K : Malignant hyperthermia during sevoflurane anesthesia in a child with central core diseas. Anesthesiology 75 : 699, 1991 https://doi.org/10.1097/00000542-199109001-00698
- Ochiai R, Toyoda Y, Nishio I, Takaeda J, Sekiguchi H, Fukushima K et al. : Possible association of malignant hyperthermia with sevoflurane anesthesia. Anesth Analg 87 : 425, 1992 https://doi.org/10.1097/00000539-199808000-00036
- Maeda H, Iranami H, Hatano Y : Delayed recovery from muscle weakness due to malignat hyperthemia during sevoflurane anesthesia. Anesthesiology 87 : 425, 1997 https://doi.org/10.1097/00000542-199708000-00031
- Wedal DJ, Gammel SA, Milde JH, Iaizzo PA : Delayed onset of malignant hyperthermia induced by isoflurane and desflurane compared with halothane in susceptible swine. Anesthesiology 78 : 1138, 1993 https://doi.org/10.1097/00000542-199306000-00018
- Snoeck MJM, Gielen A, Tangerman J : Contractures in skeletal patients after in vitro exposure to sevoflurane. Acata Anaesthesiol Scand. Mar;44(3) : 334, 2000 https://doi.org/10.1034/j.1399-6576.2000.440320.x
- Larach MG : Standardization of the caffeine halothane muscle contracture test. Anesth Analog 69 : 511, 1989
- The Europran Malignant Hyperpyrexia Group : A protocol for the investigation of malignat hyperpyrexia (MH) susceptibility. Br J Anaesth 56 : 1267, 1984 https://doi.org/10.1093/bja/56.11.1267
- Hopkin PM, Ellis FR, Halsall PJ : Comparison of in vitro contracture testing with ryanodine, halothane and caffeine in malignant hyperthermia and other neromuscular disorder. Br J Anaesth 70 : 397, 1993 https://doi.org/10.1093/bja/70.4.397
- Larach MG, Localio AR, Allen GC : A clinical grading scale the predict malignant hyperthermia susceptibility. Anesthesiology 80 : 771, 1994 https://doi.org/10.1097/00000542-199404000-00008
- Pruen BR, Mickelson JR, Roghair TJ : Effect of propofol on Ca2+ regulation by malignant hyperthermia - susceptible muscle membranes. Anesthesiology 1274, 1995 https://doi.org/10.1097/00000542-199505000-00023
- Gronert GA, Milde JH : Variations in onset of porcine malignant hyperthermia. Anesth Analg 60 : 499, 1982
- Hopkins PM: Malignant hyperthermia: advances in clinical management and diagnosis. Br J Anaesth 85 : 118, 2000 https://doi.org/10.1093/bja/85.1.118
- Davies RM Packer KJ : Malignant hyperpyrexia-two case reports. Br J Anaesth 41 : 703, 1969 https://doi.org/10.1093/bja/41.8.703
- Larach MG, Rosenberg H Larach DR : Prediction of malignant hyperthermia susceptibility by clinical signs. Anesthesiology 66 : 547, 1987 https://doi.org/10.1097/00000542-198704000-00017
- Payen JF, Bosson JL : Improved noninvasive diagnostic testing for malignant hyperthermia susceptibility from a combination of metabolites determined in vitro with 31P-magnetic resonance spectroscopy. Anesthesiology 78 : 848, 1993 https://doi.org/10.1097/00000542-199305000-00007